GlaxoSmithKline Egypt has appointed former general manager Mohamed Eldababy (LinkedIn) as its new CEO and managing director, and former vice president of performance markets Dylan Jackson (LinkedIn) as its new chairman, replacing Ashraf Mansour, Al Borsa reports.
More from Enterprise
Egypt continues to issue LCs as usual
LCs continue to be processed — albeit after closer inspection…
EGX kicks off first day of futures trading on the EGX
The rollout includes 3- and 6-month future contracts tracking the…
Gov’t to proceed with IPO plans after Eid
Good afternoon, friends, and welcome back. Still unsure where to…
Converted acquires Egyptian fashion platform Mitcha
“For me, the decision was about finding the right partner…